U.S. Physical Therapy, Inc.
USPH
$77.21
-$0.14-0.18%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 574.89M | 553.64M | 535.31M | 523.60M | 512.76M |
| Total Other Revenue | 117.43M | 110.79M | 103.76M | 97.63M | 92.92M |
| Total Revenue | 692.33M | 664.43M | 639.06M | 621.23M | 605.68M |
| Cost of Revenue | 538.43M | 514.97M | 494.73M | 481.51M | 467.61M |
| Gross Profit | 153.90M | 149.46M | 144.33M | 139.72M | 138.07M |
| SG&A Expenses | 60.45M | 58.29M | 56.62M | 54.28M | 52.18M |
| Depreciation & Amortization | 23.39M | 21.74M | 18.85M | 18.85M | 18.85M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 622.27M | 595.00M | 570.20M | 554.64M | 538.64M |
| Operating Income | 70.06M | 69.44M | 68.86M | 66.60M | 67.04M |
| Income Before Tax | 62.78M | 60.21M | 41.99M | 45.44M | 49.74M |
| Income Tax Expenses | 15.33M | 14.61M | 10.18M | 11.18M | 12.33M |
| Earnings from Continuing Operations | 47.45 | 45.60 | 31.81 | 34.26 | 37.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -14.17M | -14.18M | -8.98M | -8.80M | -8.54M |
| Net Income | 33.28M | 31.42M | 22.84M | 25.46M | 28.88M |
| EBIT | 70.06M | 69.44M | 68.86M | 66.60M | 67.04M |
| EBITDA | 90.51M | 88.12M | 85.97M | 83.28M | 83.05M |
| EPS Basic | 2.17 | 1.84 | 0.93 | 1.06 | 1.23 |
| Normalized Basic EPS | 1.76 | 1.82 | 2.32 | 2.25 | 2.30 |
| EPS Diluted | 2.17 | 1.84 | 0.93 | 1.06 | 1.23 |
| Normalized Diluted EPS | 1.76 | 1.82 | 2.32 | 2.25 | 2.30 |
| Average Basic Shares Outstanding | 60.37M | 60.26M | 60.15M | 60.06M | 58.71M |
| Average Diluted Shares Outstanding | 60.37M | 60.26M | 60.15M | 60.06M | 58.71M |
| Dividend Per Share | 1.77 | 1.76 | 1.75 | 1.74 | 1.73 |
| Payout Ratio | 79.75% | 84.46% | 115.36% | 102.72% | 83.56% |